Cosela
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Cosela, covering 2021-02-12 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer [Phase 2]